CG Oncology (CGON) Change in Inventory (2025 - 2026)

CG Oncology's (CGON) quarterly Change in Inventory came in at -$72000.0 in Q1 2026, down 212.5% on a QoQ basis from $64000.0 in Q4 2025.

CG Oncology (CGON) Change in Inventory (2025 - 2026) Analysis & Trends

CG Oncology (CGON) has 2 years of Change in Inventory data on file, last reported at -$72000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	27.70 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	28.20 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	47.15 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-2,188.52
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-280,000.00
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	12.97 Mn
10	CG Oncology	6.63 Bn	6.63 Bn	-2.77 Mn	-490,000.00

Download Data